An otherwise healthy 58-year-old man is found to have an LDL-C level of $170 \mathrm{mg} / \mathrm{dL}$, an HDL-C level of $50 \mathrm{mg} / \mathrm{dL}$, and a triglyceride level of $105 \mathrm{mg} / \mathrm{dL}$. He has no other risk factors for CHD. In addition to TLCs, which drug treatment is most appropriate for this patient?
(A) cholestyramine
(B) simvastatin
(C) niacin
(D) ezetimibe
(E) gemfibrozil